文献速递血栓与止血

母体抗父源HLA I类抗体与胎儿新生儿同种免疫性血小板减少症无关

Maternal antibodies against paternal class I human leukocyte antigens are not associated with foetal and neonatal alloimmune thrombocytopenia.
PubMed 文献 · Br J Haematol · 2020-01-29

在817对疑似FNAIT的三人家系中,母体抗HLA I类抗体与新生儿血小板计数无关,且与抗HPA-1a抗体无显著交互作用。在144例抗HPA-1a抗体所致FNAIT中,该抗体与新生儿血小板计数、出生体重及颅内出血发生率均无关。研究不支持母体抗HLA I类抗体是FNAIT或疾病严重程度的风险因素。

要点

  • 疑似FNAIT家系中,母体抗HLA I类抗体与新生儿血小板计数无关联。
  • 抗HPA-1a所致FNAIT中,抗HLA I类抗体与血小板计数、出生体重及颅内出血无关。
  • 抗HLA I类抗体与抗HPA-1a抗体之间无显著交互作用。

核心结论

  • 母体抗HLA I类抗体不增加FNAIT风险,也不加重抗HPA-1a抗体所致FNAIT的疾病严重程度。

研究设计与样本

  • 纳入817对疑似FNAIT的母亲-父亲-新生儿三人家系,评估母体抗HLA I类抗体与新生儿血小板计数及抗HPA-1a所致FNAIT发生率的关系。
  • 在144例抗HPA-1a抗体所致FNAIT中,分析母体抗HLA I类抗体与新生儿血小板计数、出生体重及颅内出血(n=16)的关联。

主要发现

  • 疑似FNAIT病例中,母体抗HLA I类抗体与新生儿血小板计数无关联。
  • 抗HLA I类抗体与抗HPA-1a抗体之间无显著交互作用。
  • 抗HPA-1a所致FNAIT中,抗HLA I类抗体与新生儿血小板计数、出生体重及颅内出血发生均无关联。

临床怎么用

  • 临床评估FNAIT风险或严重程度时,母体抗HLA I类抗体不应作为独立风险指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The causative role of maternal, anti-human leukocyte antigen (anti-HLA) class I antibodies in foetal and neonatal alloimmune thrombocytopenia (FNAIT) remains controversial. Furthermore, in FNAIT cases caused by anti-human platelet antigen-1a (anti-HPA-1a) antibodies, the possible additive effect of maternal anti-HLA class I antibodies on outcomes is unclear. Among 817 mother-father-neonate trios of suspected FNAIT, we assessed the possible association of maternal anti-HLA class I antibodies with neonatal platelet count, and the incidence of FNAIT caused by anti-HPA-1a antibodies. In 144 FNAIT cases caused by anti-HPA-1a antibodies, we investigated the possible association of maternal anti-HLA class I antibodies with neonatal platelet count, birth weight, and the incidence of intracranial haemorrhage (n = 16). Maternal anti-HLA class I antibodies were not associated with neonatal platelet count in suspected cases of FNAIT. There was no significant interaction between the presence of anti-HLA class I antibodies and anti-HPA-1a antibodies. In FNAIT cases caused by anti-HPA-1a antibodies, there was no association between the presence of anti-HLA class I antibodies and neonatal platelet count, birth weight, or occurrence of intracranial haemorrhage. This study's findings do not support the concept that maternal anti-HLA class I antibodies represent a risk factor of FNAIT or disease severity.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Sachs UJ, Wienzek-Lischka S, Duong Y, et al. Maternal antibodies against paternal class I human leukocyte antigens are not associated with foetal and neonatal alloimmune thrombocytopenia. Br J Haematol. 2020. PMID: 31997312. doi:10.1111/bjh.16419

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。